|18.00||-0.73 / -3.90%|
As of 3:59pm ET
|18.00||-0.003 / -0.02%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 26.50, with a high estimate of 28.00 and a low estimate of 25.00. The median estimate represents a +47.22% increase from the last price of 18.00.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.